{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T04:04:18Z","timestamp":1747109058019,"version":"3.40.5"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:p>Germline and somatic genetic\/genomic testing are commonly ordered for gynecologic oncology patients. Genetic tests can inform disease etiology, prognosis, treatment decisions, and risk to the patient\u2019s relatives. Variants of uncertain significance (VUSs) are frequently encountered and have a more nuanced interpretation than straightforward pathogenic or benign variant classifications. Clinical care providers should be familiar with why and how VUSs are reported, their clinical significance, variant reclassification practices, and patient perceptions of VUSs.<\/jats:p>","DOI":"10.1097\/grf.0000000000000898","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T14:02:30Z","timestamp":1727359350000},"page":"672-675","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Germline Variants of Uncertain Significance in Gynecologic Oncology Patients"],"prefix":"10.1097","volume":"67","author":[{"given":"Julia","family":"Cooper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leigha","family":"Senter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,9,26]]},"reference":[{"key":"R2-20250512","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10689-018-0086-2","article-title":"Physician interpretation of variants of uncertain significance","volume":"18","author":"Macklin","year":"2019","journal-title":"Fam Cancer"},{"key":"R3-20250512","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.amjsurg.2018.08.008","article-title":"Factors predicting reclassification of variants of unknown significance","volume":"216","author":"Wright","year":"2018","journal-title":"Am J Surg"},{"key":"R4-20250512","first-page":"PO.18.00217","article-title":"Multicenter prospective cohort study of the diagnostic yield and patient experience of multiplex gene panel testing for hereditary cancer risk","volume":"3","author":"Idos","year":"2019","journal-title":"JCO Precis Oncol"},{"key":"R5-20250512","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1200\/PO.20.00399","article-title":"Impact of variant reclassification in cancer predisposition genes on clinical care","volume":"5","author":"Chiang","year":"2021","journal-title":"JCO Precis Oncol"},{"key":"R6-20250512","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/jmg-2023-109488","article-title":"Variant reclassification and clinical implications","volume":"61","author":"Walsh","year":"2024","journal-title":"J Med Genet"},{"key":"R7-20250512","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"R8-20250512","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/GIM.0b013e31816b5cae","article-title":"ACMG recommendations for standards for interpretation and reporting of sequence variations: revisions 2007","volume":"10","author":"Richards","year":"2008","journal-title":"Genet Med"},{"key":"R9-20250512","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/s41436-020-0841-2","article-title":"The interface of genomic information with the electronic health record: a points to consider statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"22","author":"Grebe","year":"2020","journal-title":"Genet Med"},{"key":"R10-20250512","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1200\/JCO.2016.68.4316","article-title":"Conflicting interpretation of genetic variants and cancer risk by commercial laboratories as assessed by the prospective registry of multiplex testing","volume":"34","author":"Balma\u00f1a","year":"2016","journal-title":"J Clin Oncol"},{"key":"R11-20250512","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2018.13152","article-title":"Prevalence of variant reclassification following hereditary cancer genetic testing","volume":"320","author":"Mersch","year":"2018","journal-title":"JAMA"},{"key":"R12-20250512","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41436-018-0391-z","article-title":"Patient re-contact after revision of genomic test results: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"21","author":"David","year":"2019","journal-title":"Genet Med"},{"key":"R13-20250512","doi-asserted-by":"crossref","first-page":"e2300079","DOI":"10.1200\/PO.23.00079","article-title":"Practices and views of US oncologists and genetic counselors regarding patient recontact after variant reclassification: results of a nationwide survey","volume":"7","author":"Makhnoon","year":"2023","journal-title":"JCO Precis Oncol"},{"key":"R14-20250512","doi-asserted-by":"crossref","first-page":"563","DOI":"10.7326\/M22-3682","article-title":"Cases in precision medicine: is there an obligation to return reinterpreted genetic results to former patients?","volume":"176","author":"Appelbaum","year":"2023","journal-title":"Ann Intern Med"},{"key":"R15-20250512","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s12687-019-00434-7","article-title":"Patients\u2019 views on variants of uncertain significance across indications","volume":"11","author":"Clift","year":"2020","journal-title":"J Community Genet"},{"key":"R16-20250512","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/gim.2013.133","article-title":"Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium","volume":"15","author":"Berg","year":"2013","journal-title":"Genet Med"},{"key":"R18-20250512","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1245\/s10434-023-13229-5","article-title":"Surgical oncologists and nurses in breast cancer care are ready to provide pre-test genetic counseling","volume":"30","author":"Bokkers","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"R19-20250512","doi-asserted-by":"crossref","first-page":"100526","DOI":"10.1016\/j.esmoop.2022.100526","article-title":"Discrepancies between tumor genomic profiling and germline genetic testing","volume":"7","author":"Pauley","year":"2022","journal-title":"ESMO Open"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000898","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T15:08:09Z","timestamp":1747062489000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,26]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000898","relation":{},"ISSN":["0009-9201","1532-5520"],"issn-type":[{"type":"print","value":"0009-9201"},{"type":"electronic","value":"1532-5520"}],"subject":[],"published":{"date-parts":[[2024,9,26]]}}}